Castle Biosciences, Inc.
CSTL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $86 | $82 | $90 | $120 |
| Short-Term Investments | $202 | $194 | $185 | $173 |
| Receivables | $49 | $52 | $56 | $51 |
| Inventory | $9 | $8 | $7 | $8 |
| Other Curr. Assets | $12 | $12 | $11 | $8 |
| Total Curr. Assets | $358 | $349 | $349 | $360 |
| Property Plant & Equip (Net) | $100 | $90 | $67 | $63 |
| Goodwill | $11 | $11 | $11 | $11 |
| Intangibles | $91 | $93 | $67 | $96 |
| Long-Term Investments | $0 | $0 | $6 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $2 | $2 | $2 |
| Total NC Assets | $205 | $196 | $152 | $171 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $563 | $545 | $502 | $531 |
| Liabilities | – | – | – | – |
| Payables | $12 | $13 | $9 | $7 |
| Short-Term Debt | $1 | $4 | $3 | $2 |
| Tax Payable | $0 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $42 | $33 | $25 | $39 |
| Total Curr. Liab. | $55 | $51 | $37 | $49 |
| LT Debt | $36 | $34 | $23 | $24 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $3 | $1 | $2 |
| Other NC Liab. | $5 | $2 | $0 | $0 |
| Total NC Liab. | $40 | $38 | $24 | $26 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $27 | $27 | $16 | $16 |
| Total Liabilities | $96 | $89 | $61 | $75 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$222 | -$221 | -$226 | -$200 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $689 | $677 | $666 | $656 |
| Total Equity | $467 | $455 | $440 | $456 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $563 | $545 | $502 | $531 |
| Net Debt | -$48 | -$45 | -$64 | -$93 |